Magenta Therapeutics, Inc.
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
Last updated:
Abstract:
Provided herein are antibody-cytotoxin antibody-drug conjugates and related compounds, such as linker-cytotoxin conjugates and the linkers used to make them, and intermediates in their synthesis; compositions; and methods, including methods of treating cancers.
Status:
Grant
Type:
Utility
Filling date:
6 Jun 2014
Issue date:
25 Jan 2022